Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling

Marketing

General and administrative

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

FIGS

FIGS, Inc. is a direct-to-consumer healthcare apparel and lifestyle brand that seeks to celebrate, empower and serve current and future generations of healthcare professionals. It offers lab coats, underscrubs, outerwear, loungewear, compression socks, footwear, masks and face shields that are specifically designed for the needs and preferences of the medical community. Its proprietary fabric technology, called FIONx, offers four-way stretch, anti-odor, anti-wrinkle and moisture wicking properties. The company was founded by Trina Spear and Heather Hasson in 2013 and is headquartered in Santa Monica, CA.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

FIGS reports 20% revenue growth in 2022, focuses on accelerating future growth

FIGS reported strong net revenue growth in 2022, driven by nonscrubs and international sales. Despite challenges like inventory levels and macro headwinds, the company is focused on accelerating growth through product innovation and marketing strategies.
Investments in fulfillment enhancements, disciplined promotional strategies, and a cautious approach to the macro environment demonstrate a commitment to long-term brand protection and sustainable growth. Cash flow generation is expected to improve in 2023.
Opportunities lie in expanding EBITDA margins, increasing customer engagement, and leveraging the TEAMS business for growth. The company is navigating challenges like inventory normalization and short-term AUR impacts with a prudent outlook for 2023.

FIGS surpasses Q1 revenue expectations, eyes global expansion and retail growth

FIGS delivered strong Q1 results, showcasing revenue growth, operational efficiency, and customer engagement through innovative products and marketing initiatives.
While facing macro challenges, the company's focus on diversification, retail expansion, and supply chain enhancements positions it for future growth.
Maintaining a competitive edge, driving customer engagement, and capitalizing on international opportunities are key focus areas for sustained success.
Strategic initiatives to improve margins, expand retail presence, and enhance fulfillment capabilities align with FIGS' long-term growth objectives.

FIGS reports robust Q2 growth, eyes international expansion opportunities

FIGS delivered strong financial results in Q2 2023, exceeding expectations and focusing on profitability and free cash flow.
Strategic pillars for growth include product innovation, community engagement, and international expansion.
Challenges include increased operating expenses and potential flat to low single-digit net revenue growth in Q3.
Opportunities lie in expanding into new markets, enhancing the TEAMS business, and improving retail strategies.

FIGS excels in Q3 with strong revenue growth and international expansion

FIGS delivered a strong Q3 performance with notable revenue growth and improved margins.
The company's focus on international expansion, Community Hubs, and operational efficiency are key strengths.
Challenges include managing gross margin impact and maintaining promotional discipline.
Opportunities lie in market expansion, leveraging Community Hubs, and optimizing international strategies.

FIGS surpasses 2023 expectations, eyes international growth amid challenges

FIGS delivered strong financial performance in 2023, focusing on efficiency, innovation, and international growth. While facing challenges from inflation and market uncertainties in 2024, the company aims to optimize operations and drive brand engagement. Opportunities in expanding product lines, community presence, and global reach position FIGS for continued success.

FIGS exceeds Q1 revenue expectations, eyes global expansion and retail growth

FIGS delivered strong Q1 results, exceeding revenue expectations and showcasing international growth. The company's focus on product innovation, storytelling, and community engagement positions it well for future success. Challenges include managing expenses and balancing strategies for different markets, while opportunities lie in retail expansion and leveraging the growing healthcare apparel market.

FIGS reports solid Q2 earnings, eyes international growth opportunities

FIGS delivered strong Q2 results with revenue growth meeting expectations and adjusted EBITDA margin exceeding forecasts.
Despite challenges in gross margin and increased expenses, the company maintains a strong balance sheet and healthy inventory position.
Opportunities lie in international market expansion, operational efficiencies, and maintaining marketing effectiveness.
Overall, FIGS remains focused on growth, innovation, and enhancing customer engagement.

FIGS Q3 2024 Earnings: Revenue Declines Amid Strategic Growth Initiatives

FIGS faced revenue declines in Q3 2024, driven by challenges in non-scrubwear and footwear segments. Despite this, the company highlighted brand wins and strategic partnerships, with plans for international expansion and a Canadian distribution center. To drive growth, FIGS aims to focus on premium products, innovation, and operational improvements in 2025.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

FIGS, Inc. engages in the production and management of healthcare apparel and lifestyle brands. It seeks to celebrate, empower and serve current and future generations of healthcare professionals. It offers lab coats, underscrubs, outerwear, loungewear, compression socks, footwear, masks and face shields that are specifically designed for the needs and preferences of the medical community. Its proprietary fabric technology, called FIONx, offers four-way stretch, anti-odor, anti-wrinkle and moisture wicking properties. The company was founded by Trina Spear and Heather Hasson in 2013 and is headquartered in Santa Monica, CA.

Figs Inc (NYSE: FIGS) is down nearly 60% for the year but a short seller warns the stock is still trading at a significant “underserved” premium. Figs shares have downside to $4.40 On Wednesday, Spruce Point Capital Management said the healthcare apparel brand is a “strong sell” with downside to $4.

Figs shares could crash another 60%: short seller

Shares of Figs (NYSE: FIGS ) are in full focus after Spruce Point Capital released a 113-page short report on the scrubs company. The short seller alleges that Figs has no competitive advantage, inflated revenue and gross margins, and will see slower growth, which will subsequently compress valuation multiples.

Short Seller Spruce Point Says FIGS Stock Can Plunge 60% From Here

Medical apparel company FIGS Inc. FIGS, -3.71% stock slid 4% in early trade on Wednesday after Ben Axler's short-selling firm Spruce Point Management released a report slamming FIGS founders for allegedly inflating its historical revenues and "exaggerating their professional work history." The 113-page report said that co-founder Heather Hasson's work biography has "serious holes" such as not disclosing her personal bankruptcy in 2009, nor the failing of a handbag business in Italy, revealed in a related lawsuit.

FIGS shares slip after short-seller firm Spruce Point Management issues critical report

SANTA MONICA, Calif.--(BUSINESS WIRE)--FIGS, Inc. (NYSE: FIGS), the direct-to-consumer healthcare apparel and lifestyle brand, announced today that Trina Spear, Chief Executive Officer and Co-Founder, and Daniella Turenshine, Chief Financial Officer, will participate in a fireside chat at the Goldman Sachs 29th Annual Global Retailing Conference on Thursday, September 8, 2022, at 1:45 p.m. ET. The audio portion of the fireside chat will be webcast live over the internet and can be accessed at h

FIGS Announces Participation in the Goldman Sachs 29th Annual Global Retailing Conference

Hyatt Hotels

Vail Resorts

Red Rock Resorts

Tesla

Twitter

In a recent interview on CNBC's premium pro service, Ron Baron (Trades, Portfolio) of Baron Funds talked about some of the stocks he has been buying. He also offered his opinions on Elon Musk, Tesla ( TSLA , Financial) and the macroeconomic situation.

Billionaire Ron Baron Reveals 6 Stocks He Has Been Buying

Zoom Video

Follow these founders to long-term gains.

2 Founder-Led Growth Stocks With Serious Long-Term Potential

FIGS Inc. ( FIGS , Financial) operates as a direct-to-consumer health care apparel and lifestyle company in the U.S. It designs and sells health care apparel such as doctor and nurse scrubs and other non-scrub offerings, including lab coats, under scrubs, outerwear, activewear, loungewear, compression socks footwear and masks. It also offers sports bras, performance leggings, tops, super-soft pima cotton tops, vests and jackets.

Figs Has Popular and Trendy Apparel, but Is Overvalued

The "Lululemon of healthcare" looks like a buy after its fall from grace.

Down 75%, This Former Highflier Looks Like a Good Long-Term Buy

Pinterest

Investors got more optimistic about the prospects for avoiding a full recession.

These 2 Surprising Stocks Led Markets Higher Thursday

Figs Inc (NYSE: FIGS) ended nearly 20% up on Thursday after legendary investor Ron Baron said it was one of the largest investments he's made recently. How much did Baron invest in Figs?

Ron Baron reveals one of his largest recent investments

There aren't many investors with a 20-year time horizon at the age of 79, but that's exactly how far billionaire investor Ron Baron is looking ahead, and it's safe to say he's optimistic about what's to come.

Billionaire Ron Baron Is 'Incredibly Bullish' On Tesla, SpaceX And This Apparel Company He Calls 'The Lululemon Of Healthcare'

Shares of Figs (NYSE: FIGS ) are up over 10% after billionaire Ron Baron disclosed a roughly $100 million investment into the healthcare apparel company. Baron currently has a net worth of about $4.4 billion and founded Baron Capital in 1982.

Billionaire Ron Baron Is Betting Big on FIGS Stock

Airbnb

Disney

These three businesses are worth buying and holding forever despite recently higher share prices.

3 Growth Stocks Up Between 27% and 30% In the Last Month: Should You Buy Now?

FIGS, Inc. (NYSE:FIGS ) Q2 2022 Earnings Conference Call August 4, 2022 5:00 PM ET Company Participants Todd Maron - Chief Legal Officer Catherine Spear - Chief Executive Officer Daniella Turenshine - Chief Financial Officer Conference Call Participants Edward Yruma - Piper Sandler Adrienne Yih - Barclays Lorraine Hutchinson - Bank of America Robert Drbul - Guggenheim Partners Brian Nagel - Oppenheimer Rick Patel - Raymond James Brooke Roach - Goldman Sachs John Kernan - Cowen and Company Noah Zatzkin - KeyBanc Capital Markets Operator Hello, everyone, and welcome to the FIGS Second Quarter 2022 Earnings Conference Call. My name is Victoria, and I will be coordinating your call today.

FIGS, Inc. (FIGS) CEO Catherine Spear on Q2 2022 Results - Earnings Call Transcript

Figs (FIGS) delivered earnings and revenue surprises of 50% and 2.74%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Figs (FIGS) Q2 Earnings and Revenues Surpass Estimates

SANTA MONICA, Calif.--(BUSINESS WIRE)--FIGS, Inc. (NYSE: FIGS) (the “Company”), the direct-to-consumer healthcare apparel and lifestyle brand, today released its second quarter 2022 financial results and published a financial highlights presentation on its investor relations website at ir.wearfigs.com/financials/quarterly-results/. Second Quarter 2022 Financial Highlights Net revenues were $122.2 million, an increase of 20.9% year over year, driven by an increase in orders as a result of strong

FIGS Releases Second Quarter 2022 Financial Results

Figs (FIGS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Figs (FIGS) Reports Next Week: Wall Street Expects Earnings Growth

SANTA MONICA, Calif.--(BUSINESS WIRE)--FIGS, Inc. (NYSE: FIGS), the direct-to-consumer healthcare apparel and lifestyle brand, today announced it will release its second quarter 2022 financial results on Thursday, August 4, 2022, after U.S. markets close. FIGS management will host a conference call that day at 2:00 p.m. PT / 5:00 p.m. ET to discuss its financial and business results and outlook. Prior to the call, FIGS will publish a second quarter 2022 financial highlights presentation on its

FIGS Announces Date of Second Quarter 2022 Earnings Release, Conference Call and Webcast

Canada Goose Holdings

GOOS vs. FIGS: Which Stock Is the Better Value Option?

GOOS vs. FIGS: Which Stock Should Value Investors Buy Now?

The shares of Figs Inc (NYSE:FIGS) are up 5.4% to trade at $8.74, after Raymond James initiated coverage on the healthcare apparel name with a "strong buy" and $15 price target.

Healthcare Retail Stock Rises on Fresh Analyst Coverage

Burberry Group PLC

BURBY vs. FIGS: Which Stock Is the Better Value Option?

BURBY vs. FIGS: Which Stock Should Value Investors Buy Now?

SAN DIEGO--(BUSINESS WIRE)---- $FIGS #ClassActionAttorney--Robbins LLP Reminds Investors it is Investigating FIGS, Inc. (FIGS) on Behalf of Shareholders

FIGS STOCKHOLDER NEWS: Robbins LLP Reminds Investors It Is Investigating FIGS, Inc. (FIGS) on Behalf of Shareholders

SAN DIEGO--(BUSINESS WIRE)---- $FIGS #FIGSInc--Robbins LLP Investigates FIGS, Inc. (FIGS) on Behalf of Shareholders

FIGS STOCK NEWS: Robbins LLP Investigates FIGS, Inc. (FIGS) on Behalf of Shareholders

Crocs

Opportunities abound for investors with a long-term time horizon.

News for FIGS Stock (FIGS)